ARCHIVES

Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association.

This article is from The Cancer Letter archive.

Vol. 30 No. 31 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

Dexamethasone Improved Survival Of Leukemia

November 26, 2004

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

In Brief: Reagan Okays Reauthorization; Harold Freeman ACS President, Robert Schweitzer President Elect

November 11, 1988

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007